Tech Company Financing Transactions
Resolve Therapeutics Funding Round
Resolve Therapeutics secured a $1.1 million investment round on 4/26/2012. Backers included private investors.
Transaction Overview
Company Name
Announced On
4/26/2012
Transaction Type
Debt
Amount
$1,083,334
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
721 1st Ave. N
St. Petersburg, FL 33701
USA
St. Petersburg, FL 33701
USA
Phone
Undisclosed
Website
Email Address
Overview
Resolve Therapeutics is a privately held biotechnology company based in Seattle that is dedicated to helping patients with lupus through the development of RSLV-125, its novel targeted biologic therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Peter Kiener
Chief Executive Officer
James Posada
VP - Manufacturing
Raj Dua
Browse more venture capital transactions:
Prev: 4/26/2012: SingleHop venture capital transaction
Next: 4/26/2012: Parchment venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs